Home > Healthcare > Medical Devices > Therapeutic Devices > Nebulizers Market
Nebulizers Market Size
Nebulizers Market size was worth more than USD 783 million in 2022 and is estimated to record significant growth at around 9.5% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.
Respiratory ailments have been spreading increasingly owing to the high level of air pollution. Moreover, smoking and occupational exposures cause airway blockage, which leads to COPD. Nebulizers help to ensure that the proper medicine is delivered to the right location in the respiratory system. Research has indicated that using nebulizers can improve outcomes for conditions, including seasonal flu brought on by weather changes, chronic obstructive pulmonary disease (COPD), bronchitis, and even asthma. The National Institute for Health Statistics estimates that 25 million Americans suffer from asthma.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 783 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 9.5% |
| 2032 Value Projection: | USD 1.9 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 310 |
| Tables, Charts & Figures: | 577 |
| Segments covered: | Product, Portability, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Prolonged drug delivery time to limit product uptake
Customers have considerable issues with traditional nebulizers because of their size, long treatment duration, and power needs, which is hindering the nebulizers market expansion. Drug delivery with nebulizers is a time-consuming process that results in significant medication loss while constantly operating nebulizers. Nebulizers have persistently low lung delivery efficiency and need lengthy delivery periods for high-dose drugs. The airflow rate that powers the nebulizer affects how long it takes to deliver the drug.
Nebulizers Market Analysis
In terms of product, the jet nebulizers market is anticipated to reach over USD 1.2 billion by 2032. Emphysema, lower respiratory infections, and pulmonary hypertension are among the various respiratory diseases that affect the elderly population. Nebulizers and other inhaled medication therapy are necessary for the treatment of such morbidities. Jet nebulizers are inexpensive and require minimal effort from the patient to produce an aerosol, which is a major factor driving product demand.
Based on portability, the nebulizers market from the tabletop segment is projected to be worth more than USD 1 billion by 2032. The availability of advantageous reimbursement policies in various countries, as well as the operational benefits afforded by these devices, are set to facilitate segment progress. Tabletop nebulizers are highly preferred for young children who routinely receive treatments since they come in fun designs and are also available with activity boards that help keep children occupied during their treatments.
Nebulizers market is classified based on end-use into medical and homecare. The homecare segment is set to witness lucrative growth at over 9.5% CAGR through 2032 owing to the rising popularity of homecare nebulizer equipment as well as the expanding geriatric population base suffering from respiratory ailments. Additionally, the widespread availability of innovative and compact nebulizers integrated with new technologies that minimize their noise and enhance their functionality makes them ideal for use at home. This has increased their uptake in home healthcare, which is anticipated to bolster segment development.
North America nebulizers market accounted for over 38% of the overall industry revenue in 2022. The regional industry is poised to exhibit robust growth between 2023 and 2032 resulting from the high cases of respiratory disorders and chronic diseases. Around 9 million Americans are diagnosed with COPD, however, this figure might be significantly higher as over 18 million persons have indications of impaired lung function that could indicate undiagnosed COPD. Major government and healthcare organizations, including the American Lung Association, are working on reducing the burden of lung diseases and lung cancer through education and support programs for patients, which is expected to raise the demand for nebulizers for treatment.
Nebulizers Market Share
- Sunset Healthcare Solutions
- Omron Corporation
- PARI Respiratory Equipment, Inc.
- Allied Healthcare Products, Inc.
- Koninklijke Philips N.V.
- VYAIRE MEDICAL, INC.
- Vectura Group Ltd
- Lepu Medical Technology (Beijing) Co. Ltd.
- and GF Health Products, Inc.
are some of the leading companies operating in the market. Businesses are adopting new technologies, designing special drug delivery devices, and creating cutting-edge products to expand their global reach.
The nebulizers market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD and units from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
- Jet nebulizers
- Vented
- Breath actuated
- Ultrasonic nebulizers
- Mesh nebulizers
- Nebulizers accessories
By Portability
- Portable / handheld
- Tabletop
By End-use
- Medical
- Hospitals & clinics
- Emergency centers
- ASCs
- Homecare
The above information is provided for the following geographies:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Poland
- Switzerland
- Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- Indonesia
- Thailand
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Columbia
- Middle East
- South Africa
- Saudi Arabia
- UAE
- Israel
Frequently Asked Questions (FAQ) :